Sella turcica: an anatomical, endocrinological, and historical perspective.

Abstract:

INTRODUCTION:The sphenoid bone has a superior depression called the sella turcica, Latin for "Turkish saddle," where the pituitary gland is found. The availability of modern radiological imaging techniques has replaced plain radiography of the sella turcica in the investigation of hypothalamo-pituitary abnormalities. However, the size of the sella turcica, and smaller sella turcica size in particular, may cause pituitary dysfunction because of the changes in the structure of pituitary gland or may be associated with some genetic or acquired endocrine disorders. The name "sella turcica" is one of the most commonly used terms in everyday endocrine practice. METHODS:In this review, after a brief explanation of the anatomical and endocrinological features of the sella turcica had been given, a historical perspective of sella turcica nomenclature was presented for the first time. FINDINGS AND CONCLUSIONS:After Andreas Vesalius's description of it as a suitable cavity for the gland that receives the "phlegm of the brain" in De Humani Corporis Fabrica (1543), medical scholars began to use seat/saddle-related terms such as the ephippium, pars sellaris, sella equina, sella ossis, and sella sphenoidalis. The real designation of the sella turcica, however, was introduced to the anatomical nomenclature by the anatomist Adrianus Spigelius (1578-1625) in his famous work De Corpora Humanis Fabrica (1627).

journal_name

Pituitary

journal_title

Pituitary

authors

Tekiner H,Acer N,Kelestimur F

doi

10.1007/s11102-014-0609-2

subject

Has Abstract

pub_date

2015-08-01 00:00:00

pages

575-8

issue

4

eissn

1386-341X

issn

1573-7403

journal_volume

18

pub_type

历史文章,杂志文章,评审
  • Isolated familial somatotropinomas: clinical features and analysis of the MEN1 gene.

    abstract::Isolated familial somatotropinomas (IFS) rarely occurs in the absence of multiple endocrine neoplasia type I (MEN1) or the Carney complex. In the present study we report two Italian siblings affected by GH-secreting adenomas. There was no history of parental consanguinity. The sister presented at 18 years of age with ...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1023/a:1022193015993

    authors: De Menis E,Prezant TR

    更新日期:2002-01-01 00:00:00

  • Screening for Cushing's syndrome: is it worthwhile?

    abstract:INTRODUCTION:Cushing's syndrome (CS) is a rare disease characterized by a collection of signs and symptoms, also common in the general population without elevated cortisol secretion. During the last years more patients with CS are identified earlier and with milder disease. Many of these patients are diagnosed during s...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-015-0634-9

    authors: Shimon I

    更新日期:2015-04-01 00:00:00

  • Clinical characteristics of acromegalic patients with empty sella and their outcomes following transsphenoidal surgery.

    abstract:PURPOSE:To analyze the clinical characteristics of acromegalic patients with empty sella (ES, herniation of the subarachnoid space within the sella turcica) and the impact of ES on transsphenoidal surgery in such patients. METHODS:Seventy-eight patients, newly diagnosed with acromegaly who underwent transsphenoidal su...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-017-0798-6

    authors: Sasagawa Y,Hayashi Y,Tachibana O,Oishi M,Fukui I,Iizuka H,Nakada M

    更新日期:2017-08-01 00:00:00

  • Evaluation of survivin splice variants in pituitary tumors.

    abstract:PURPOSE:Survivin is an apoptosis inhibitor, expressed in almost all types of human malignancies, but rarely in differentiated normal tissues. Recently, survivin gene splice variants with different anti-apoptotic activities have been reported. The current study was undertaken to examine the expression of survivin and it...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-014-0590-9

    authors: Waligórska-Stachura J,Andrusiewicz M,Sawicka-Gutaj N,Kubiczak M,Jankowska A,Liebert W,Czarnywojtek A,Waśko R,Blanco-Gangoo AR,Ruchała M

    更新日期:2015-06-01 00:00:00

  • Adamantinomatous craniopharyngiomas express tumor stem cell markers in cells with activated Wnt signaling: further evidence for the existence of a tumor stem cell niche?

    abstract:INTRODUCTION:Early disease onset, clinical manifestation, histomorphology, and increased tendency to relapse distinguish the adamantinomatous craniopharyngioma (adaCP) from the more favorable papillary variant (papCP). A molecular hallmark of adaCP is the activated Wnt signaling pathway indicated by nuclear β-catenin a...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-013-0543-8

    authors: Hölsken A,Stache C,Schlaffer SM,Flitsch J,Fahlbusch R,Buchfelder M,Buslei R

    更新日期:2014-12-01 00:00:00

  • "Micromegaly": an update on the prevalence of acromegaly with apparently normal GH secretion in the modern era.

    abstract:PURPOSE:Approximately 25 % of cases of clinically active acromegaly cases treated in our academic center between 1996 and 2000, were diagnosed in patients who had elevated plasma IGF-1 levels, but apparently "normal" 24-h mean plasma GH levels. The current study served to update the data for patients with acromegaly re...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-016-0735-0

    authors: Butz LB,Sullivan SE,Chandler WF,Barkan AL

    更新日期:2016-12-01 00:00:00

  • A prospective longitudinal study of Pasireotide in Nelson's syndrome.

    abstract:PURPOSE:Nelson's syndrome is a challenging condition that can develop following bilateral adrenalectomy for Cushing's disease, with high circulating ACTH levels, pigmentation and an invasive pituitary tumor. There is no established medical therapy. The aim of the study was to assess the effects of pasireotide on plasma...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-017-0853-3

    authors: Daniel E,Debono M,Caunt S,Girio-Fragkoulakis C,Walters SJ,Akker SA,Grossman AB,Trainer PJ,Newell-Price J

    更新日期:2018-06-01 00:00:00

  • Craniopharyngioma surgery.

    abstract::Ideal surgical treatment of craniopharyngiomas remains a major challenge for neurosurgeons. Craniopharyngiomas grow in the deep-seated hypothalamic area that is paramount for vegetative, emotional and endocrine function, and for maintaining worthwhile life. The benign histological nature of craniopharyngiomas belies t...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-008-0137-z

    authors: Honegger J,Tatagiba M

    更新日期:2008-01-01 00:00:00

  • Combined treatment of invasive giant prolactinomas.

    abstract::The management of invasive giant prolactinomas (IGP) has been an area of some controversy. The relative roles of transsphenoidal surgery, craniotomy, radiation therapy and dopamine agonist based medical therapy are gradually becoming clarified. We report the results of management of 30 patients with IGP. Surgery was t...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-005-5087-0

    authors: Yu C,Wu Z,Gong J

    更新日期:2005-01-01 00:00:00

  • Moderate dose cranial radiotherapy causes central adrenal insufficiency in long-term survivors of childhood leukaemia.

    abstract::Acute lymphoblastic leukaemia (ALL) is the most common childhood malignancy. The survival rate in the Scandinavian countries is now around 85 %. ALL patients treated with cranial radiotherapy (CRT) are at risk for growth hormone deficiency (GHD), but little is known about other pituitary insufficiencies, e.g. ACTH. Ad...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-012-0459-8

    authors: Follin C,Wiebe T,Moëll C,Erfurth EM

    更新日期:2014-02-01 00:00:00

  • Cabergoline decreases somatotroph adenoma size: a case report.

    abstract::Dopamine agonists have been shown to reduce growth hormone secretion in some patients with acromegaly, but their effect on adenoma size has not been well appreciated. We describe a 69 year-old woman with acromegaly caused by a somatotroph macroadenoma who received primary treatment with the dopamine agonist cabergolin...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-005-5353-1

    authors: Rickels MR,Snyder PJ

    更新日期:2004-01-01 00:00:00

  • Epidemiology of acromegaly.

    abstract::Acromegaly is a consequence of chronic growth hormone (GH) excess, due in the majority of cases to a GH-secreting pituitary adenoma, and occurring with a population prevalence of 60 per million and an incidence of 3-4 per million per year. Males and females appear to be equally affected with an average age of presenta...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1023/a:1009965803750

    authors: Holdaway IM,Rajasoorya C

    更新日期:1999-06-01 00:00:00

  • Effects of low dose versus high dose human growth hormone on body composition and lipids in adults with GH deficiency: a meta-analysis of placebo-controlled randomized trials.

    abstract:PURPOSE:Doses of growth hormone in adults with growth hormone deficiency are now lower than previously. However, it is not clear they are as effective as higher doses. The objective of this meta-analysis was to assess efficacy of low to moderate dose (LD) GH replacement on standard endpoints of GH compared to higher do...

    journal_title:Pituitary

    pub_type: 杂志文章,meta分析,评审

    doi:10.1007/s11102-014-0571-z

    authors: Newman CB,Carmichael JD,Kleinberg DL

    更新日期:2015-06-01 00:00:00

  • Radiotherapy in paediatric Cushing's disease: efficacy and long term follow up of pituitary function.

    abstract::Pituitary radiotherapy (RT) is an effective second-line treatment for paediatric Cushing's disease (CD). We report long-term efficacy and anterior pituitary function in a cohort of paediatric CD patients treated with RT. Between 1988 and 2008, from our cohort of 48 paediatric CD patients, eight paediatric CD patients ...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-010-0231-x

    authors: Acharya SV,Gopal RA,Goerge J,Menon PS,Bandgar TR,Shah NS

    更新日期:2010-12-01 00:00:00

  • Phospho-histone H3 (pHH3) immuno-reactivity as a prognostic marker in non-functioning pituitary adenomas.

    abstract::Nonfunctioning pituitary adenomas (NFPA) are typically benign neoplasms that can cause significant morbidity through local mass effects. MIB-1/Ki-67 and p53 immuno-reactivity are used to predict aggressive behavior but have known limitations. No marker to date is widely used to reliably predict tumor progression. Phos...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-011-0367-3

    authors: Hightower E,Cabanillas ME,Fuller GN,McCutcheon IE,Hess KR,Shah K,Waguespack SG,Corley LJ,Devin JK

    更新日期:2012-12-01 00:00:00

  • Lanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry.

    abstract::Lanreotide depot (LD; commercial name Somatuline(®) Depot) is an injectable, extended-release formulation of the synthetic somatostatin analog (SSA) lanreotide. In recent clinical trials, LD was found to be suitable for self or partner administration, avoiding the need to travel to a medical facility. The Somatuline(®...

    journal_title:Pituitary

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s11102-012-0460-2

    authors: Salvatori R,Woodmansee WW,Molitch M,Gordon MB,Lomax KG

    更新日期:2014-02-01 00:00:00

  • Fall in thyroid stimulating hormone (TSH) may be an early marker of ipilimumab-induced hypophysitis.

    abstract:PURPOSE:Hypophysitis develops in up to 19% of melanoma patients treated with ipilimumab, a cytotoxic T-lymphocyte antigen-4 antibody. Early detection may avert life-threatening hypopituitarism. We aimed to assess the incidence of ipilimumab-induced hypophysitis (IH) at a quaternary melanoma referral centre, and to dete...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-018-0866-6

    authors: De Sousa SMC,Sheriff N,Tran CH,Menzies AM,Tsang VHM,Long GV,Tonks KTT

    更新日期:2018-06-01 00:00:00

  • Management of recurrent pituitary cysts with pituitary-nasal drain.

    abstract::Pituitary cysts are usually craniopharyngiomas or remnants of Rathke's cleft. Histologically craniopharyngiomas are lined by stratified squamous epithelium whereas Rathke's cleft cysts are lined by cuboidal or columnar epithelium. The management of pituitary cysts remains difficult because of the risks associated with...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1023/a:1025373715860

    authors: Dashora U,Mathias D,James A,Zammit-Maempel I,Perros P

    更新日期:2002-01-01 00:00:00

  • Endoscopic endonasal approach for pituitary adenomas: a series of 555 patients.

    abstract:PURPOSE:To report the results of a consecutive series of patients who underwent an endoscopic endonasal approach (EEA) for resection of a pituitary adenoma and compare them to previous series of microscopic and endoscopic approaches. METHODS:A retrospective review of clinical and radiographic outcomes of a consecutive...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-013-0502-4

    authors: Paluzzi A,Fernandez-Miranda JC,Tonya Stefko S,Challinor S,Snyderman CH,Gardner PA

    更新日期:2014-08-01 00:00:00

  • Histopathological classification of non-functioning pituitary neuroendocrine tumors.

    abstract::Non-functioning pituitary neuroendocrine tumors do not cause endocrine symptoms related to hypersecretion of adenohypophyseal hormones and are clinically characterized by symptoms due to growing sellar tumor mass. Histopathological classification of this tumor group has always been challenging due to their heterogenei...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-017-0855-1

    authors: Manojlovic-Gacic E,Engström BE,Casar-Borota O

    更新日期:2018-04-01 00:00:00

  • Monotherapy with lanreotide depot for acromegaly: long-term clinical experience in a pituitary center.

    abstract:PURPOSE:Long-acting somatostatin analogs are one of the main classes of medical therapy used for acromegaly and most patients require ongoing treatment. Few studies have evaluated the long-term efficacy and safety of lanreotide depot beyond 2 years. The goal of this study was to provide a long-term longitudinal assessm...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-016-0724-3

    authors: Sagvand BT,Khairi S,Haghshenas A,Swearingen B,Tritos NA,Miller KK,Klibanski A,Nachtigall LB

    更新日期:2016-08-01 00:00:00

  • What are critical outcome measures for patients receiving pituitary replacement following brain injury?

    abstract::There are scant prospective studies defining improvements in critical outcome measures with hormone replacement in hypopituitarism secondary to brain injury. We review the tests of cognition and physical function and summarize their use for subjects that are deficient in anterior hormone production during anterior pit...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-008-0133-3

    authors: Beca SG,High WM Jr,Masel BE,Mossberg KA,Urban RJ

    更新日期:2012-03-01 00:00:00

  • Pathology of prolactinomas: any predictive value?

    abstract::Lactotroph adenomas, also called prolactinomas and prolactin-secreting adenomas, constitute nearly 80% of functioning pituitary tumors and about 30-50% of all adenomas in the clinical practice. Lactotroph adenomas occur in the general population at a prevalence of 45/100,000, are more common in women, but also involve...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-019-00997-1

    authors: Lopes MBS

    更新日期:2020-02-01 00:00:00

  • Acromegaly as a cause of 1,25-dihydroxyvitamin D-dependent hypercalcemia: case reports and review of the literature.

    abstract::Growth hormone excess has been associated with hypercalciuria and nephrolithiasis. Hypercalcemia in acromegaly is rare and usually due to coexistent primary hyperparathyroidism. To report two cases of 1,25-dihydroxyvitamin D (1,25 (OH)(2) D)-dependent hypercalcemia in cromegaly. A 50 year-old female with 2 years histo...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-010-0286-8

    authors: Shah R,Licata A,Oyesiku NM,Ioachimescu AG

    更新日期:2012-12-01 00:00:00

  • Glucocorticoid inhibition of growth in rats: partial reversal with the full-length ghrelin analog BIM-28125.

    abstract::Glucocorticoids are important immunosuppressive hormones; these steroids also inhibit somatic growth by decreased growth hormone (GH) secretion and induced protein catabolism. The ability of ghrelin, the endogenous ligand for the GHS-1a receptor, to increase body weight is attributed to a combination of enhanced food ...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-007-0054-6

    authors: Tulipano G,Taylor JE,Halem HA,Datta R,Dong JZ,Culler MD,Bianchi I,Cocchi D,Giustina A

    更新日期:2007-01-01 00:00:00

  • The metabolic consequences of thyroxine replacement in adult hypopituitary patients.

    abstract::The metabolic consequences of thyroxine replacement in patients with central hypothyroidism (CH) need to be evaluated. The aim was to examine the outcome of thyroxine replacement in CH. Adult hypopituitary patients (n = 1595) with and without CH from KIMS (Pfizer International Metabolic Database) were studied before a...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-011-0356-6

    authors: Filipsson Nyström H,Feldt-Rasmussen U,Kourides I,Popovic V,Koltowska-Häggström M,Jonsson B,Johannsson G

    更新日期:2012-12-01 00:00:00

  • Clinical features of sellar and suprasellar meningiomas.

    abstract::Meningiomas account for about 1% of sellar masses. Although they can mimic pituitary adenomas, they are more vascularized and invasive. To gain insights that would enhance our ability to establish a pre-surgical diagnosis of meningioma, we performed a retrospective study of these tumors. Query of the surgical patholog...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-013-0507-z

    authors: Kwancharoen R,Blitz AM,Tavares F,Caturegli P,Gallia GL,Salvatori R

    更新日期:2014-08-01 00:00:00

  • Cis-unsaturated free fatty acids block VIP-mediated GH and PRL secretion by perturbing the cAMP/protein kinase A pathway.

    abstract::Cis-unsaturated free fatty acids (FFA) like oleic acid are strong blockers of both basal and stimulated GH secretion in vivo by acting directly on the somatotroph cell. Several lines of evidence suggest that this inhibitory action is the result of a perturbation of the function of several plasma membrane integral prot...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1023/a:1009962624036

    authors: Pérez FR,Camiña JP,Menéndez C,Beiras A,Casabiell X,Casanueva FF

    更新日期:1998-04-01 00:00:00

  • Can tissue biomarkers reliably predict the biological behavior of craniopharyngiomas? A comprehensive overview.

    abstract:BACKGROUND:The growing interest in the molecular and genetic alterations of craniopharyngiomas (CPs) is embodied in recent studies revealing insights into the CP tumorigenesis and identifying novel molecular pathways amenable of targeted therapies. The actual impact of this new information, however, remains inconclusiv...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-018-0890-6

    authors: Prieto R,Pascual JM

    更新日期:2018-08-01 00:00:00

  • IGF-I assays: current assay methodologies and their limitations.

    abstract::The diagnosis of disorders of growth hormone (GH) is dependent upon accurate measurement of insulin-like growth factor-I (IGF-I) concentrations since serum IGF-I assays have been found to be useful as a screening tests for the presence of growth hormone deficiency (GHD) in children and in both children and adults they...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-007-0032-z

    authors: Clemmons DR

    更新日期:2007-01-01 00:00:00